Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review.

Autor: van Dijk MJ; Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Oirschot BA; Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Stam-Slob MC; Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Waanders E; Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van der Zwaag B; Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Beers EJ; Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Jans JJM; Section Metabolic Diagnostics, Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van der Linden PW; Department of Internal Medicine, Spaarne Gasthuis, Haarlem, The Netherlands., Torregrosa Diaz JM; Service d'Hématologie et Thérapie Cellulaire, Pôle Régional de Cancérologie, University Hospital of Poitiers, Poitiers, France., Gardie B; Nantes University, CHU Nantes, CNRS, INSERM, Nantes, France.; Ecole Pratique des Hautes Etudes (EPHE), Université Paris Sciences et Lettres, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Girodon F; Laboratory of Excellence GR-Ex, Paris, France.; Service d'Hématologie Biologique, Pôle Biologie, Centre Hospitalier Universitaire (CHU) de Dijon, Dijon, France.; INSERM U1231, Université de Bourgogne, Dijon, France., Schots R; Department of Hematology, Universitair Ziekenhuis Brussel - VUB, Brussels, Belgium., Thielen N; Division of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands., van Wijk R; Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (2), pp. 249-255. Date of Electronic Publication: 2022 Sep 30.

Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

Autor: Schuurhuizen CSEW; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam.; Department of Psychiatry and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam., Braamse AMJ; Department of Medical Psychology, Cancer Center Amsterdam, Amsterdam Public Health Institute, Academic Medical Center, Amsterdam., Beekman ATF; Department of Psychiatry and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam., Cuijpers P; Department of Clinical Psychology, VU University, Amsterdam., van der Linden MHM; Department of Medical Psychology, and., Hoogendoorn AW; Department of Psychiatry and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam., Berkhof H; Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam., Sommeijer DW; Department of Medical Oncology, Flevoziekenhuis, Almere., Lustig V; Department of Medical Oncology, Flevoziekenhuis, Almere., Vrijaldenhoven S; Department of Medical Oncology, Noordwest Ziekenhuisgroep, Alkmaar., Bloemendal HJ; Department of Medical Oncology, Meander Medical Center, Amersfoort., van Groeningen CJ; Department of Medical Oncology, Hospital Amstelland, Amstelveen., van Zweeden AA; Department of Medical Oncology, Hospital Amstelland, Amstelveen., van der Vorst MJDL; Department of Medical Oncology, Rijnstate Hospital, Arnhem., Rietbroek R; Department of Medical Oncology, Red Cross Hospital, Beverwijk., Tromp-van Driel CS; Department of Medical Oncology, Noordwest Ziekenhuisgroep, Den Helder., Wymenga MNW; Department of Medical Oncology, Medisch Spectrum Twente, Enschede., van der Linden PW; Department of Medical Oncology, Spaarne Gasthuis, Haarlem., Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp., Polee MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden., Batman E; Department of Medical Oncology, Alrijne Hospital, Leiden., Los M; Department of Medical Oncology, St. Antonius Hospital, Nieuwegein., van Bochove A; Department of Medical Oncology, Zaans Medical Center, Zaandam; and., Brakenhoff JAC; Department of Medical Oncology, Waterland Hospital, Purmerend, the Netherlands., Konings IRHM; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam., Verheul HMW; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam., Dekker J; Department of Psychiatry and Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam.

Publikováno v: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2019 Aug 01; Vol. 17 (8), pp. 911-920.

CA 19-9 as a marker in addition to CEA to monitor colorectal cancer.

Autor: Stiksma J; Department of Oncology, Internal Medicine, Kennemer Gasthuis, Haarlem, The Netherlands; Faculty of Medicine, VU Medical Centre, Amsterdam, The Netherlands., Grootendorst DC; Department of Oncology, Internal Medicine, Kennemer Gasthuis, Haarlem, The Netherlands; Linnaeus Institute, Kennemer Gasthuis, Haarlem, The Netherlands; Landsteiner Institute, Medical Center Haaglanden, The Hague, The Netherlands., van der Linden PW; Department of Oncology, Internal Medicine, Kennemer Gasthuis, Haarlem, The Netherlands. Electronic address: pw.vdlinden@kg.nl.

Publikováno v: Clinical colorectal cancer [Clin Colorectal Cancer] 2014 Dec; Vol. 13 (4), pp. 239-44. Date of Electronic Publication: 2014 Sep 18.

Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.

Autor: De Wee EM; Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands., Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2012 May; Vol. 18 (3), pp. 444-51. Date of Electronic Publication: 2011 Sep 12.

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.

Autor: Mauser-Bunschoten EP; Van Creveldkliniek and Hematology, University Medical Centre Utrecht, Utrecht, The Netherlands., Kleine Budde I, Lopaciuk S, Koopman MM, Van Der Meer FJ, Novàkovà IR, Ypma P, Van Der Linden PW, Windyga J, Strengers PF

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2011 May; Vol. 17 (3), pp. 439-45. Date of Electronic Publication: 2011 Mar 01.